Condition
H.Pylori Gastrointestinal Disease
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Completed2
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06579365RecruitingPrimary
Argentinean Registry on the Management of Helicobacter Pylori Infection
NCT05577572Not ApplicableUnknownPrimary
Second Line Bismuth Containing Quadruple Therapy With Supplementary Probiotic
NCT03592069Phase 4Completed
Concomitant Versus Hybrid Regimen for H. Pylori Eradication
NCT02487511Phase 4CompletedPrimary
Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy
Showing all 4 trials